MedTrace Logo

Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.

NCT03541330 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2025-12-11

No results posted yet for this study

Summary

The primary objective is to evaluate the experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy at the Centre Hospitalier Régional et Universitaire of Lille

Conditions

  • Malignant Haemopathy

Interventions

OTHER

semi-directive interview

semi-structured interview conducted by a clinical psychologist

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Eva De Berranger, MD · University Hospital, Lille

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-22
Primary Completion
2019-04-01
Completion
2019-04-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03541330 on ClinicalTrials.gov